Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.53 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.53 |
| ▸ | PTAFR | P25105 | 18/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8928579 | 0.92 | OPRK1 (0.43) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928766 | 0.92 | OPRK1 (0.42) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928442 | 0.92 | OPRK1 (0.54) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928546 | 0.89 | OPRK1 (0.51) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928805 | 0.88 | OPRK1 (0.53) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928561 | 0.85 | RECQL (0.38) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928748 | 0.84 | OPRK1 (0.42) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928672 | 0.84 | OPRK1 (0.43) | OPRK1PDE4DPTAFRCYP3A4ALOX15 | |
| SCHEMBL8928710 | 0.81 | RECQL (0.38) | OPRK1MEN1KMT2A | |
| SCHEMBL8928420 | 0.81 | OPRK1 (0.59) | OPRK1PDE4DPTAFRCYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0776892-A1 | THIENYLAZOLE COMPOUND AND THIENOTRIAZOLODIAZEPINE COMPOUND | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1997-06-04 | — | — | EP | disclosed |